Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

Seikagaku Corporation

Clinical trials sponsored by Seikagaku Corporation, explained in plain language.

Seikagaku Corporation 4548 TOKYO

A biopharmaceutical company focused on glycoscience-based products.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Completed 1
Sort by
  • New eye drop shows promise for dry eye sufferers in Late-Stage trial

    Symptom relief Completed

    This Phase 3 trial tested SI-614 eye drops, a modified form of sodium hyaluronate, against placebo in 232 adults with dry eye disease. Participants used the drops four times daily for 84 days. The study measured changes in eye surface staining (a sign of damage) and daily symptom…

    Phase: PHASE3 • Sponsor: Seikagaku Corporation • Aim: Symptom relief

    Last updated Jun 27, 2026 08:12 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse About Terms of use Contact us

This is a site from Cyber and Space